Surescripts Settles with FTC Over Charges of Anticompetitive Behavior | Healthcare IT Today
The Federal Trade Commission has filed a proposed order settling charges that e-prescribing giant Surescripts used anticompetitive business practices to monopolize two e-prescription drug markets.
The order follows on the heels of a prior federal…